What Is Mangoceuticals, Inc. (MGRX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Mangoceuticals, Inc.'s intrinsic value is estimated at a composite fair value of $0.43. Trading at $0.39, the stock is approaching fair value or slight overvaluation (implied return of +9.1%), as 7 of 12 models suggest limited further upside. The most optimistic model, RCMH-DCF, places fair value at $1.77 (+351.7%), while First Chicago — the most conservative — estimates $0.04 (-90.5%). This +442.2% gap reflects genuine analytical uncertainty about Mangoceuticals, Inc.'s intrinsic worth.
What Do the Models Say About MGRX?
12 of 13 models are currently active for MGRX. Of these, 5 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates MGRX's intrinsic value at $0.09, implying -77.4% downside from the current price. See which stocks rank higher →
How Does MGRX Rank in Services-Misc Health & Allied Services, NEC?
Among 11 Services-Misc Health & Allied Services, NEC stocks, MGRX ranks #7 by Quality of Company score. CirclFi's QOC score of 5.2/10 evaluates 32 fundamental signals. A score of 5.2 reflects mixed fundamentals.
Mangoceuticals, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is MGRX a Value Trap?
CirclFi's Value Trap algorithm assigns MGRX a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Mangoceuticals, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Mangoceuticals, Inc. earns a quality score of 5.2/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +442.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every MGRX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across MGRX's 12 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad